Showing results (181-190 of 14,086) with videos related to
Sort By:
Pageof 1,409
Gynecologic Oncology|March 26, 1998
Response to salvage treatment in recurrent ovarian cancer treated initially with paclitaxel and platinum-based combination regimensP Y Roland, M N Barnes, S Niwas, et al.Gynecologic Oncology|March 26, 1998
Ovarian metastasis of stage IB1 squamous cell cancer of the cervix after radical parametrectomy and oophoropexyL Nguyen, C A Brewer, P J DiSaiaGynecologic Oncology|April 19, 2015
A phase II evaluation of selumetinib (AZD6244, ARRY-142886), a selective MEK-1/2 inhibitor in the treatment of recurrent or persistent endometrial cancer: an NRG Oncology/Gynecologic Oncology Group studyRobert L Coleman, Michael W Sill, Premal H Thaker, et al.Gynecologic Oncology|August 11, 2016
Early warning score: An indicator of adverse outcomes in postoperative patients on a gynecologic oncology serviceHaller J Smith, Daniel N Pasko, Christen L Walters Haygood, et al.Gynecologic Oncology|November 1, 1984
Survival and recurrence patterns in the radiation treatment of carcinoma of the vaginaA M Chu, R BeechinorGynecologic Oncology|November 1, 1984
Synchronous carcinomas of the uterine corpus and ovaryR J Zaino, E R Unger, C WhitneyGynecologic Oncology|August 1, 1983
Metronidazole as a radiosensitizer and high-dose radiation in advanced vulvovaginal malignancies, a pilot studyD Nori, J M Cain, B S Hilaris, et al.Gynecologic Oncology|August 1, 1983
Tamoxifen-induced increase in cytosol progestin receptor levels in a case of metastatic endometrial cancerP E Schwartz, N MacLusky, F Naftolin, et al.Gynecologic Oncology|June 1, 1983
Epithelial carcinoma of the ovary in the reproductive years: clinical and morphological characterizationU Beller, B Bigelow, E M Beckman, et al.Pageof 1,409